Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-02-24 Sale | 2026-02-26 4:23 pm | Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC Kutzkey Tim Svennilson Peter 10% Owner | 4,170,266 | $0.57075 | $2,380,189 | 49,313,559 (Indirect) | View |
| 2026-02-20 Sale | 2026-02-24 4:13 pm | Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC Kutzkey Tim Svennilson Peter 10% Owner | 829,734 | $0.60837 | $504,787 | 51,525,316 (Indirect) | View |
| 2026-02-17 Sale | 2026-02-17 7:15 pm | Tenaya Therapeutics Inc. | TNYA | Higa Tomohiro SVP, Finance | 3,469 | $0.64323 | $2,231 | 119,752 (Direct) | View |
| 2026-02-17 Sale | 2026-02-17 7:14 pm | Tenaya Therapeutics Inc. | TNYA | Ali Faraz Chief Executive Officer | 14,862 | $0.64303 | $9,557 | 443,404 (Direct) | View |
| 2026-02-17 Sale | 2026-02-17 7:13 pm | Tenaya Therapeutics Inc. | TNYA | Tingley Whittemore Chief Medical Officer | 5,160 | $0.64316 | $3,319 | 218,618 (Direct) | View |
| 2026-02-10 Sale | 2026-02-12 5:19 pm | Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC Kutzkey Tim Svennilson Peter 10% Owner | 4,400,290 | $0.69137 | $3,042,222 | 51,965,376 (Indirect) | View |
| 2025-11-17 Sale | 2025-11-17 8:34 pm | Tenaya Therapeutics Inc. | TNYA | Higa Tomohiro SVP, Finance | 1,367 | $1.33 | $1,818 | 93,971 (Direct) | View |
| 2025-11-17 Sale | 2025-11-17 8:34 pm | Tenaya Therapeutics Inc. | TNYA | Tingley Whittemore Chief Medical Officer | 2,877 | $1.33 | $3,826 | 169,926 (Direct) | View |
| 2025-11-17 Sale | 2025-11-17 8:33 pm | Tenaya Therapeutics Inc. | TNYA | Ali Faraz Chief Executive Officer | 3,126 | $1.33 | $4,158 | 299,666 (Direct) | View |
| 2025-08-18 Sale | 2025-08-18 9:00 pm | Tenaya Therapeutics Inc. | TNYA | Higa Tomohiro SVP, Finance | 2,962 | $1.253 | $3,711 | 95,338 (Direct) | View |
| 2025-08-18 Sale | 2025-08-18 8:59 pm | Tenaya Therapeutics Inc. | TNYA | Tingley Whittemore Chief Medical Officer | 5,053 | $1.253 | $6,331 | 172,803 (Direct) | View |
| 2025-08-18 Sale | 2025-08-18 8:58 pm | Tenaya Therapeutics Inc. | TNYA | Ali Faraz Chief Executive Officer | 14,533 | $1.253 | $18,210 | 302,792 (Direct) | View |
| 2025-05-16 Sale | 2025-05-16 7:07 pm | Tenaya Therapeutics Inc. | TNYA | Higa Tomohiro SVP, Finance | 1,390 | $0.4427 | $615 | 98,300 (Direct) | View |
| 2025-05-16 Sale | 2025-05-16 7:07 pm | Tenaya Therapeutics Inc. | TNYA | Tingley Whittemore Chief Medical Officer | 2,937 | $0.4427 | $1,300 | 171,856 (Direct) | View |
| 2025-05-16 Sale | 2025-05-16 7:07 pm | Tenaya Therapeutics Inc. | TNYA | Ali Faraz Chief Executive Officer | 3,189 | $0.4427 | $1,412 | 317,325 (Direct) | View |
| 2025-03-10 Sale | 2025-03-10 9:44 pm | Tenaya Therapeutics Inc. | TNYA | Higa Tomohiro SVP, Finance | 2,482 | $0.5384 | $1,336 | 99,690 (Direct) | View |
| 2025-03-10 Sale | 2025-03-10 9:43 pm | Tenaya Therapeutics Inc. | TNYA | Tingley Whittemore Chief Medical Officer | 7,398 | $0.5384 | $3,983 | 174,793 (Direct) | View |
| 2025-03-10 Sale | 2025-03-10 9:42 pm | Tenaya Therapeutics Inc. | TNYA | Ali Faraz Chief Executive Officer | 9,741 | $0.5384 | $5,245 | 320,514 (Direct) | View |
| 2025-03-05 Purchase | 2025-03-07 7:14 pm | Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner | 35,714,284 | $0.7 | $24,999,999 | 112,285,275 (Indirect) | View |
| 2025-03-05 Purchase | 2025-03-07 7:14 pm | Tenaya Therapeutics Inc. | TNYA | GOEDDEL DAVID V Director 10% Owner | 35,714,284 | $0.7 | $24,999,999 | 112,285,275 (Indirect) | View |
| 2024-11-18 Sale | 2024-11-18 8:48 pm | Tenaya Therapeutics Inc. | TNYA | Saito Chihiro SVP, Accounting and Fin. Ops. | 2,258 | $2.12 | $4,787 | 60,983 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-03 Option Award | 2026-02-05 6:03 pm | 2026-03-03 2036-02-02 | Tenaya Therapeutics Inc. | TNYA | Higa Tomohiro SVP, Finance | 204,750 | $0 | 298,721 (Direct) | View |
| 2026-02-03 Option Award | 2026-02-05 6:02 pm | 2026-03-03 2036-02-02 | Tenaya Therapeutics Inc. | TNYA | Tingley Whittemore Chief Medical Officer | 367,250 | $0 | 542,278 (Direct) | View |
| 2026-02-03 Option Award | 2026-02-05 6:02 pm | 2026-03-03 2036-02-02 | Tenaya Therapeutics Inc. | TNYA | Ali Faraz Chief Executive Officer | 1,110,850 | $0 | 1,410,516 (Direct) | View |
| 2025-05-29 Option Award | 2025-05-30 6:54 pm | 2026-05-29 2035-05-28 | Tenaya Therapeutics Inc. | TNYA | Stehman-Breen Catherine Director | 107,400 | $0 | 107,400 (Direct) | View |
| 2025-05-29 Option Award | 2025-05-30 6:53 pm | 2026-05-29 2035-05-28 | Tenaya Therapeutics Inc. | TNYA | Walsh Jeffrey T. Director | 107,400 | $0 | 107,400 (Direct) | View |
| 2025-05-29 Option Award | 2025-05-30 6:52 pm | 2026-05-29 2035-05-28 | Tenaya Therapeutics Inc. | TNYA | Burroughs Amy L. Director | 107,400 | $0 | 107,400 (Direct) | View |
| 2025-05-29 Option Award | 2025-05-30 6:52 pm | 2026-05-29 2035-05-28 | Tenaya Therapeutics Inc. | TNYA | GOEDDEL DAVID V Director 10% Owner | 107,400 | $0 | 107,400 (Direct) | View |
| 2025-05-29 Option Award | 2025-05-30 6:51 pm | 2026-05-29 2035-05-28 | Tenaya Therapeutics Inc. | TNYA | Williams R Sanders Director | 107,400 | $0 | 107,400 (Direct) | View |
| 2025-05-29 Option Award | 2025-05-30 6:50 pm | 2026-05-29 2035-05-28 | Tenaya Therapeutics Inc. | TNYA | Srivastava Deepak Director | 107,400 | $0 | 107,400 (Direct) | View |
| 2025-05-29 Option Award | 2025-05-30 6:50 pm | 2026-05-29 2035-05-28 | Tenaya Therapeutics Inc. | TNYA | Lee June Director | 107,400 | $0 | 107,400 (Direct) | View |
| 2025-05-29 Option Award | 2025-05-30 6:48 pm | 2026-05-29 2035-05-28 | Tenaya Therapeutics Inc. | TNYA | Parschauer Karah Herdman Director | 107,400 | $0 | 107,400 (Direct) | View |
Ownership | 2025-02-07 8:30 pm | N/A N/A | Tenaya Therapeutics Inc. | TNYA | Higa Tomohiro SVP, Finance | 0 | $0 | 250,453 (Direct) | View |
| 2025-02-06 Option Award | 2025-02-07 8:29 pm | 2025-03-06 2035-03-05 | Tenaya Therapeutics Inc. | TNYA | Ali Faraz Chief Executive Officer | 1,707,799 | $0 | 1,896,130 (Direct) | View |
| 2025-01-24 Option Award | 2025-01-28 8:00 pm | 2025-02-24 2035-01-23 | Tenaya Therapeutics Inc. | TNYA | Tingley Whittemore Chief Medical Officer | 937,658 | $0 | 1,044,764 (Direct) | View |
| 2024-10-18 Option Award | 2024-10-21 8:43 pm | 2025-05-31 2034-10-17 | Tenaya Therapeutics Inc. | TNYA | Walsh Jeffrey T. Director | 34,000 | $0 | 34,000 (Direct) | View |
| 2024-10-18 Option Award | 2024-10-21 8:42 pm | 2025-05-31 2034-10-17 | Tenaya Therapeutics Inc. | TNYA | Williams R Sanders Director | 34,000 | $0 | 34,000 (Direct) | View |
| 2024-10-18 Option Award | 2024-10-21 8:41 pm | 2025-05-31 2034-10-17 | Tenaya Therapeutics Inc. | TNYA | Stehman-Breen Catherine Director | 34,000 | $0 | 34,000 (Direct) | View |
| 2024-10-18 Option Award | 2024-10-21 8:40 pm | 2025-05-31 2034-10-17 | Tenaya Therapeutics Inc. | TNYA | Srivastava Deepak Director | 34,000 | $0 | 34,000 (Direct) | View |
| 2024-10-18 Option Award | 2024-10-21 8:39 pm | 2025-05-31 2034-10-17 | Tenaya Therapeutics Inc. | TNYA | Parschauer Karah Herdman Director | 34,000 | $0 | 34,000 (Direct) | View |